Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Pharmaceutical Design
|
May 11, 2022
Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study
Valeria Catalani, Michelle Botha, John Martin Corkery, et al.
Frontiers in Psychiatry
|
February 26, 2021
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Valeria Catalani, Davide Arillotta, John Martin Corkery, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
Valeria Catalani, Michelle Botha, John Martin Corkery, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 5, 2016
A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases
Fabio Vaiano, Francesco P Busardò, Diego Palumbo, et al.
Chemical Biology & Drug Design
|
July 15, 2022
In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines
Valeria Catalani, Giuseppe Floresta, Michelle Botha, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 15, 2021
Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise
Valeria Catalani, John Martin Corkery, Amira Guirguis, et al.
Plos One
|
June 16, 2023
Illicit COVID-19 products online: A mixed-method approach for identifying and preventing online health risks
Valeria Catalani, Honor D Townshend, Mariya Prilutskaya, et al.
Forensic Science International
|
January 7, 2017
3-MeO-PCP intoxication in two young men: First in vivo detection in Italy
Elisabetta Bertol, Jennifer Pascali, Diego Palumbo, et al.
Brain Sciences
|
November 25, 2023
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, et al.
Drugs
|
April 27, 2022
Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals
Fabrizio Schifano, Valeria Catalani, Safia Sharif, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Pharmaceutical Design
|
May 11, 2022
Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study
Valeria Catalani, Michelle Botha, John Martin Corkery, et al.
Frontiers in Psychiatry
|
February 26, 2021
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Valeria Catalani, Davide Arillotta, John Martin Corkery, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
Valeria Catalani, Michelle Botha, John Martin Corkery, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 5, 2016
A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases
Fabio Vaiano, Francesco P Busardò, Diego Palumbo, et al.
Chemical Biology & Drug Design
|
July 15, 2022
In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines
Valeria Catalani, Giuseppe Floresta, Michelle Botha, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 15, 2021
Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise
Valeria Catalani, John Martin Corkery, Amira Guirguis, et al.
Plos One
|
June 16, 2023
Illicit COVID-19 products online: A mixed-method approach for identifying and preventing online health risks
Valeria Catalani, Honor D Townshend, Mariya Prilutskaya, et al.
Forensic Science International
|
January 7, 2017
3-MeO-PCP intoxication in two young men: First in vivo detection in Italy
Elisabetta Bertol, Jennifer Pascali, Diego Palumbo, et al.
Brain Sciences
|
November 25, 2023
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, et al.
Drugs
|
April 27, 2022
Correction to: Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals
Fabrizio Schifano, Valeria Catalani, Safia Sharif, et al.
Page
of 2